New hope: liver transplant plus Chemo-Radiotherapy targets deadly bile duct cancer
NCT ID NCT04378023
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 30 times
Summary
This study tests a new approach for people with a type of bile duct cancer that cannot be removed by surgery. Patients first receive chemotherapy and radiation, then a liver transplant. The goal is to see if this combination helps patients live longer and keeps the cancer from coming back. The trial will include 34 patients aged 70 or younger with small tumors and no spread to lymph nodes or other organs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of HPB Surgery and Transplants, Hospital Vall d´Hebron
RECRUITINGBarcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.